Property Summary

NCBI Gene PubMed Count 60
PubMed Score 39.29
PubTator Score 38.05

Knowledge Summary


No data available


  Disease Sources (2)

Disease Target Count P-value
Breast cancer 3099 2.07213997269231E-13
malignant mesothelioma 3163 5.91242629352182E-7
acute quadriplegic myopathy 1157 3.41218747780005E-6
medulloblastoma, large-cell 6234 6.69871602986779E-6
osteosarcoma 7933 7.87462205931661E-6
ovarian cancer 8492 1.69506928375059E-5
psoriasis 6685 1.1331451490388E-4
lung cancer 4473 1.28532041189788E-4
dermatomyositis 967 2.05327384183497E-4
Multiple myeloma 1328 2.56079231132267E-4
group 3 medulloblastoma 2254 7.02756885542455E-4
hepatocellular carcinoma 550 0.00171790404739455
diabetes mellitus 1663 0.00283041918136511
glioblastoma 5572 0.00284649344417111
Waldenstrons macroglobulinemia 765 0.00948698295708109
primitive neuroectodermal tumor 3031 0.0180874801505464
aldosterone-producing adenoma 664 0.0266051976248538
Disease Target Count Z-score Confidence
Frontotemporal dementia 47 3.076 1.5


  Differential Expression (17)

Disease log2 FC p
hepatocellular carcinoma -1.500 0.002
Waldenstrons macroglobulinemia 1.599 0.009
Multiple myeloma 2.249 0.000
malignant mesothelioma 1.500 0.000
psoriasis 1.300 0.000
osteosarcoma -1.430 0.000
group 3 medulloblastoma 2.400 0.001
glioblastoma 1.300 0.003
medulloblastoma, large-cell 1.300 0.000
primitive neuroectodermal tumor 1.200 0.018
acute quadriplegic myopathy 1.138 0.000
lung cancer -1.800 0.000
diabetes mellitus -1.100 0.003
aldosterone-producing adenoma -1.030 0.027
Breast cancer -1.200 0.000
ovarian cancer 2.200 0.000
dermatomyositis 1.500 0.000


Accession P62995 B4DVK2 D3DNU3 O15449 Q15815 Q64283 TRA-2 beta
Symbols SFRS10



2CQC   2KXN   2RRA   2RRB  

  Ortholog (9)

Species Source
Macaque OMA EggNOG Inparanoid
Mouse OMA Inparanoid
Rat OMA Inparanoid
Cow OMA Inparanoid
Opossum OMA EggNOG
Platypus OMA EggNOG Inparanoid
Chicken OMA EggNOG Inparanoid
Xenopus OMA EggNOG Inparanoid
Fruitfly OMA Inparanoid

Gene RIF (28)

26298634 that TRA2beta promotes glioma cell growth and migration, and could be a candidate for molecular targeting during gene therapy treatments of glioma
26261585 Tra2beta was significantly upregulated in prostate carcinoma, and multivariate analysis confirmed Tra2beta as an independent prognostic factor.
26013829 SRPK1 is a regulator of Tra2beta1 splicing function and individual domains engage in considerable cross-talk, assuming novel functions with regard to RNA binding, splicing, and catalysis.
25970345 Overexpression of either Tra2alpha or Tra2beta results in a marked reduction in HIV-1 Gag/ Env expression.
25970345 HIV-1 Env synthesis is enhanced (slightly) by endogeneous levels of TRA2B; shRNA knockdown of TRA2B reduces Env synthesis slightly (~2 fold) in the HeLa rtTA HIVdletamls cell line (contains stably integrated, doxycycline (Dox) inducible HIV-1 provirus)
25970345 Multiply spliced HIV-1 RNA is increased by TRA2B overexpression resulting in blocking of HIV-1 genomic RNA export
25884434 Results showed that HNRNPG and HTRA2-BETA1 were specific antagonistic regulators of ERa exon7 splicing and increased HNRNPG levels were associated with improved clinical outcome of endometrial cancer through up-regulation of ERaD7 expression.
25416801 HIV-1 Env synthesis is enhanced (slightly) by endogeneous levels of TRA2B; shRNA knockdown of TRA2B reduces Env synthesis slightly (~2 fold) in the HeLa rtTA HIVdletamls cell line (contains stably integrated, doxycycline (Dox) inducible HIV-1 provirus)
25342468 findings suggest that Tra2beta regulates apoptosis by modulating Bcl-2 expression through its competition with miR-204. This novel function may have a crucial role in tumor growth.
25208576 Simultaneous depletion of Tra2alpha and Tra2beta induces substantial shifts in splicing of endogenous Tra2beta target exons, and both constitutive and alternative target exons are under dual Tra2alpha-Tra2beta control.

AA Sequence

RSYSPRRY                                                                  281 - 288

Text Mined References (69)

PMID Year Title
26298634 2015 Knocking down the expression of TRA2? inhibits the proliferation and migration of human glioma cells.
26261585 2015 Prognostic value of transformer 2? expression in prostate cancer.
26013829 2015 Intra-domain Cross-talk Regulates Serine-arginine Protein Kinase 1-dependent Phosphorylation and Splicing Function of Transformer 2?1.
25970345 2015 Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression.
25884434 2015 HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer.
25342468 2015 Transformer 2? and miR-204 regulate apoptosis through competitive binding to 3' UTR of BCL2 mRNA.
25231870 2014 Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.
25208576 2014 Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons.
24952301 2014 Transformer 2? (Tra2?/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation.
24865968 2014 HuR regulates alternative splicing of the TRA2? gene in human colon cancer cells under oxidative stress.